Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Plus Erlotinib in Advanced Renal Carcinoma
NCT00425386Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Aug 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in renal cell carcinoma (RCC), sponsored by OHSU Knight Cancer Institute. Started Aug 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00425386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425386.